Prostate Cancer Coverage From Every Angle
Advertisement
Advertisement

Recent News

Northwestern Medicine Receives $10 Million Gift to Create Urologic Cancer Institute
Cyclohexanone Curcumin Analogs May Hinder Progression of Castration-Resistant Prostate Cancer
Predicting Aggressive Prostate Cancer in Black Men
NICE Recommends Noninvasive MRI Screening for Prostate Cancer
Clinical Practice Guideline on Hypofractionated Radiation Therapy for Localized Prostate Cancer
Does the Timing of Androgen-Deprivation Therapy Affect Outcomes in Prostate Cancer?
Shedding Light on Resistance to Hormone Therapy in Prostate Cancer
Chemoradiotherapy Plus Hormonal Therapy in Localized Prostate Cancer: Late Toxicity Analysis
NCRI Cancer Conference: Men With Prostate Cancer Balance Quality of Life and Survival
ESMO 2018: Responses to Rucaparib in Men With HRR-Deficient Prostate Cancer
ESMO 2018: Enzalutamide in Men With Nonmetastatic Castration-Resistant Prostate Cancer
ASTRO 2018: Response to Radiotherapy in African American Men With Prostate Cancer
ESMO 2018: Does Local Radiotherapy Improve Survival in Some Men With Prostate Cancer?
ASTRO 2018: Stereotactic Body Radiation for Low- and Intermediate-Risk Prostate Cancer
ESMO 2018: 12-Year Follow-up With Docetaxel-Based Chemotherapy in High-Risk Prostate Cancer
International Cancer Immunotherapy Conference: Early Study Results of Vaccine in HER2-Positive Cancers
Prostate Cancer Foundation Releases First National Report on Prostate Cancer Awareness
FDA Grants Breakthrough Therapy Designation to Rucaparib in Metastatic Prostate Cancer
Is Alcohol Intake Earlier in Life Associated With High-Grade Prostate Cancer?
Updated NCCN Guidelines for Prostate Cancer: New Treatment Options Added
Prostate Cancer Research Funded by U.S. Department of Defense
Does Addition of Abiraterone to Enzalutamide Therapy Benefit Men With Prostate Cancer?
Prostate Cancer Foundation Funds 2018 Young Investigator Awards
Early Detection of Metastatic Prostate Cancer: Impact on Incidence and Survival
Novel Gene-Expression Model and Molecular Subtype of Prostate Cancer
Long-Term Androgen-Deprivation Therapy With Radiotherapy for Locally Advanced Prostate Cancer
Projected Prostate Cancer Rates in Patients Living With HIV
NIH and Prostate Cancer Foundation to Study Prostate Cancer in African American Men
Update on PROSPECT: Phase III Trial of Prostate Cancer Vaccine
Olaparib Combined With Abiraterone for Metastatic Castration-Resistant Prostate Cancer
Comprehensive Sequencing of Metastatic Prostate Cancer Identifies Clinically Significant Subgroups
ESHRE 2018: Risk of Prostate Cancer in Men Treated With Intracytoplasmic Sperm Injection


By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.